We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+5.45%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$274M
AUM Growth
+$28.9M
Cap. Flow
+$18.1M
Cap. Flow %
6.61%
Top 10 Hldgs %
33.26%
Holding
58
New
20
Increased
13
Reduced
10
Closed
11

Top Buys

Rank Stock Value
1
A icon
Agilent Technologies
A
+$9.27M
2
ISRG icon
Intuitive Surgical
ISRG
+$7.55M
3
COR icon
Cencora
COR
+$6.22M
4
WAT icon
Waters Corp
WAT
+$5.87M
5
FMS icon
Fresenius Medical Care
FMS
+$5.48M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.66M
2
ELV icon
Elevance Health
ELV
+$6.42M
3
LLY icon
Eli Lilly
LLY
+$5.91M
4
CAH icon
Cardinal Health
CAH
+$5.36M
5
GH icon
Guardant Health
GH
+$5.29M

Sector Composition

Rank Sector Weight
1 Healthcare 98.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
1
Zimmer Biomet
ZBH
$18.4B
$10.4M 3.79%
66,950
+5,150
+8% +$798K
THC icon
2
Tenet Healthcare
THC
$21.1B
$10.4M 3.79%
200,000
+30,000
+18% +$1.52M
A icon
3
Agilent Technologies
A
$41.2B
$9.54M 3.48%
+75,000
New +$9.27M
MDT icon
4
Medtronic
MDT
$112B
$9.45M 3.45%
80,000
BSX icon
5
Boston Scientific
BSX
$71.5B
$8.7M 3.17%
225,000
+25,000
+13% +$946K
IQV icon
6
IQVIA
IQV
$39.3B
$8.69M 3.17%
45,000
UHS icon
7
Universal Health Services
UHS
$10.5B
$8.67M 3.16%
65,000
SYK icon
8
Stryker
SYK
$130B
$8.53M 3.11%
35,000
+5,000
+17% +$1.2M
DHR icon
9
Danaher
DHR
$144B
$8.44M 3.08%
42,300
-2,820
-6% -$573K
HUM icon
10
Humana
HUM
$46.2B
$8.38M 3.06%
20,000
+2,500
+14% +$998K
MOH icon
11
Molina Healthcare
MOH
$10.3B
$8.18M 2.98%
35,000
+2,500
+8% +$557K
CNC icon
12
Centene
CNC
$32.5B
$7.99M 2.91%
125,000
+50,000
+67% +$3.1M
TMO icon
13
Thermo Fisher Scientific
TMO
$220B
$7.99M 2.91%
17,500
+2,500
+17% +$1.19M
ABT icon
14
Abbott
ABT
$187B
$7.79M 2.84%
65,000
-10,000
-13% -$1.18M
CTLT
15
DELISTED
CATALENT, INC.
CTLT
$7.63M 2.78%
72,500
+17,500
+32% +$1.95M
HCA icon
16
HCA Healthcare
HCA
$89.5B
$7.53M 2.75%
40,000
-20,000
-33% -$3.53M
UNH icon
17
UnitedHealth
UNH
$370B
$7.44M 2.71%
20,000
ISRG icon
18
Intuitive Surgical
ISRG
$134B
$7.39M 2.69%
+30,000
New +$7.55M
EHC icon
19
Encompass Health
EHC
$12.4B
$7.37M 2.69%
113,130
+56,565
+100% +$3.69M
BDX icon
20
Becton Dickinson
BDX
$48.2B
$7.29M 2.66%
30,750
+2,562
+9% +$626K
COR icon
21
Cencora
COR
$61.2B
$6.79M 2.48%
+57,500
New +$6.22M
BAX icon
22
Baxter International
BAX
$14.2B
$6.75M 2.46%
80,000
+5,000
+7% +$397K
CRL icon
23
Charles River Laboratories
CRL
$12.8B
$6.52M 2.38%
22,500
+2,500
+13% +$695K
LH icon
24
Labcorp
LH
$25.9B
$6.38M 2.33%
29,100
-8,730
-23% -$1.75M
WAT icon
25
Waters Corp
WAT
$39.9B
$6.11M 2.23%
+21,500
New +$5.87M

Similar funds

Sivik Global Healthcare's Q1 2021 Portfolio in Review

As of Q1 2021, Sivik Global Healthcare held 58 positions worth $274M, up 12% from $245M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Sivik Global Healthcare deployed $18.1M of net new capital in Q1 2021, opening 20 new positions and adding to 13 existing holdings. Its largest new stake was Agilent Technologies: 75,000 shares worth $9.54M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

On the sell side, the largest reduction was Guardant Health, an estimated $5.29M trimmed.

  • Sivik Global Healthcare's largest Q1 2021 buy was Agilent Technologies: 75,000 shares worth $9.54M.
  • Sivik Global Healthcare added most to Encompass Health in Q1 2021, an estimated $3.69M increase.
  • Sivik Global Healthcare's biggest Q1 2021 reduction was Guardant Health, cutting an estimated $5.29M.
  • Sivik Global Healthcare fully exited Regeneron Pharmaceuticals in Q1 2021, selling an estimated $9.66M.
  • Sivik Global Healthcare's ten largest holdings make up 33% of its $274M portfolio in Q1 2021.
  • Sivik Global Healthcare opened 20 new positions and closed 11 in Q1 2021.
  • Sivik Global Healthcare's portfolio value rose 12% quarter-over-quarter to $274M.

Based on Sivik Global Healthcare's 13F filing for Q1 2021, filed 12 May 2021.